Clinical trial

Abatacept With Methotrexate- Phase IIB

NCT00162266

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-10-01

PhasePHASE2

Study timeline

Study start (unknown)2000-10-01Date precision: month

Registry last updated2012-06-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Abatacept (BMS-188667)DRUG

PlaceboDRUG

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

ChicagoIllinois, United States1 DallasTexas, United States1 TorontoOntario, Canada1 ParisFrance1 BirminghamAlabama, United States1 PortlandOregon, United States1 BerlinGermany1 MontrealQuebec, Canada1 AustinTexas, United States1 The BronxNew York, United States1 BrusselsBelgium1 AlbuquerqueNew Mexico, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00162266 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.